News
One great example of a “what the hell is happening here” story run just the other day that opened with, “Orange juice, known ...
Replimune Group's RP1 oncolytic virus therapy faced an FDA rejection, raising concerns about the platform's viability in ...
One of the most notable accomplishments of the first Trump Administration was its willingness to take on the status quo of ...
Sarepta Therapeutics (SRPT) stock in focus as report says company hired a Trump-linked lobbying firm after deaths linked to ...
23h
Medpage Today on MSNCDC Funds Frozen; Prasad Didn't Reject Replimune; Filling the Gender Care GapThe amount of frozen funds could be as high as $200 million, or potentially more than $300 million, according to two ...
The US Department of Health and Human Services has terminated 22 mRNA vaccine research contracts under BARDA, signaling a ...
Laura Loomer, a far-right activist once banned from social media, has become an influential, unofficial advisor to Donald ...
New evidence of effectiveness is cause to drop a Biden restriction on Medicare coverage for anti-amyloid treatments.
Laura Loomer has been dubbed “Trump’s Rasputin” as her influence grows with her quest to oust administration officials she ...
You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life ...
Laura Loomer names the MAGA rep she says the Trump admin ‘can’t stand’ - Loomer testifies in HBO lawsuit deposition that a high-profile congresswoman is disliked, despite her outspoken loyalty to the ...
This is the online version of Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up here to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results